The Curious Case of the Baffling Biological
Author:
Affiliation:
1. National Cancer Institute, Bethesda, MD
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2000.18.10.2007
Reference32 articles.
1. Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma
2. Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon
3. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
4. Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma
5. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group;Leukemia Research;2018-10
2. Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials;Journal of Clinical Oncology;2017-02-10
3. Retrospective Analysis of Toxicity Profiles of two Platinum-Based Salvage Regimens in Relapsed/ Refractory Lymphoma: DHAP versus ESHAP.;International Journal of Hematology and Oncology;2016-03-01
4. Current role of FDG PET/CT in lymphoma;European Journal of Nuclear Medicine and Molecular Imaging;2014-02-12
5. Antibody and Immunomodulatory Agents in the Treatment of Indolent Non-Hodgkin’s Lymphoma;Seminars in Hematology;2008-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3